Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec;196(4):e32095.
doi: 10.1002/ajmg.c.32095. Epub 2024 Jul 18.

Expanding the phenotype of neurofibromatosis type 1 microdeletion syndrome

Jenny P Garzon  1   2 , Andrea Patete  1   2 , Lindsey Aschbacher-Smith  3   4 , Dima Qu'd  5 , Geraldine Kelly-Mancuso  3   4 , Carolyn R Raski  1   2 , Allison Goetsch Weisman  1   2 , Madison Hankins  1   2 , Michael Sawin  1   2 , Katherine Kim  1   2 , Andy Drackley  1   2 , Janice Zeid  6   7 , K Nicole Weaver  3   4 , Robert J Hopkin  3   4 , Howard M Saal  3   4 , Joel Charrow  1   2 , Elizabeth Schorry  3   4 , Robert Listernick  1   2 , Brittany N Simpson  3   4   8   9   10 , Carlos E Prada  1   2
Affiliations

Expanding the phenotype of neurofibromatosis type 1 microdeletion syndrome

Jenny P Garzon et al. Am J Med Genet C Semin Med Genet. 2024 Dec.

Abstract

Neurofibromatosis type 1 (NF-1) microdeletion syndrome accounts for 5 to 11% of individuals with NF-1. The aim of our study was to characterize a large cohort of individuals with NF-1 microdeletion syndrome and expand its natural history. We conducted a retrospective chart review from 1994 to 2024 of individuals with NF-1 microdeletion syndrome followed at two large Neurofibromatosis Clinics. This cohort consists of 57 individuals with NF-1 microdeletion syndrome (28 type-1, 4 type-2, 2 type-3, 9 atypical deletions, and 14 indeterminate). We note 38/56 (67.9%) with describable facial features, 25/57 (43.8%) with plexiform neurofibromas, and 3/57 (5.2%) with malignant peripheral nerve sheath tumors within the observed period. The most reported neurodevelopmental manifestations from school-age or older individuals included 39/49 (79.6%) with developmental delays, 35/49 (71.4%) with expressive and/or receptive speech delays, 33/41 (80.5%) with learning difficulties, and 23/42 (54.8%) with attention-deficit/hyperactivity disorder. Full-scale IQ testing data was available for 22 individuals (range: 50-96). Of the 21 adults in this cohort, 14/21 (66.7%) graduated from high school, and 4/21 (19.0%) had some college experience. Many individuals received academic support (i.e., special education, individual education plan). In this cohort, neurocognitive outcomes in adults varied more than typically reported in the literature.

Keywords: Neurofibromatosis type 1; cognitive deficits; intellectual disability; microdeletion syndrome; tumors.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: The authors declare no conflicts of interest.

References

    1. Ballester R, Marchuk D, Boguski M, Saulino A, Letcher R, Wigler M, & Collins F (1990). The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell, 63(4), 851–859. 10.1016/0092-8674(90)90151-4 - DOI - PubMed
    1. Basel-Vanagaite L, Dallapiccola B, Ramirez-Solis R, Segref A, Thiele H, Edwards A, Arends MJ, Miro X, White JK, Desir J, Abramowicz M, Dentici ML, Lepri F, Hofmann K, Har-Zahav A, Ryder E, Karp NA, Estabel J, Gerdin AK, … Borck G (2012). Deficiency for the ubiquitin ligase UBE3B in a blepharophimosis-ptosis-intellectual-disability syndrome. Am J Hum Genet, 91(6), 998–1010. 10.1016/j.ajhg.2012.10.011 - DOI - PMC - PubMed
    1. Bianchessi D, Morosini S, Saletti V, Ibba MC, Natacci F, Esposito S, Cesaretti C, Riva D, Finocchiaro G, & Eoli M (2015). 126 novel mutations in Italian patients with neurofibromatosis type 1. Mol Genet Genomic Med, 3(6), 513–525. 10.1002/mgg3.161 - DOI - PMC - PubMed
    1. Buki G, Zsigmond A, Czako M, Szalai R, Antal G, Farkas V, Fekete G, Nagy D, Szell M, Tihanyi M, Melegh B, Hadzsiev K, & Bene J (2021). Genotype-Phenotype Associations in Patients With Type-1, Type-2, and Atypical NF1 Microdeletions. Front Genet, 12, 673025. 10.3389/fgene.2021.673025 - DOI - PMC - PubMed
    1. Cnossen MH, de Goede-Bolder A, van den Broek KM, Waasdorp CM, Oranje AP, Stroink H, Simonsz HJ, van den Ouweland AM, Halley DJ, & Niermeijer MF (1998). A prospective 10 year follow up study of patients with neurofibromatosis type 1. Arch Dis Child, 78(5), 408–412. 10.1136/adc.78.5.408 - DOI - PMC - PubMed

MeSH terms

Supplementary concepts

LinkOut - more resources